James Rule writes for Los Angeles Times, April 27, 2015
You don’t need to be a conspiracy theorist to foresee a Faustian bargain—consent to a totally monitored world—emerging from these trends. Our greatest concern should not be unauthorized access to our data, but access by interests rightfully entitled to exploit any data known to exist.
Megan McCracken and Jennifer Moreno write for The National Law Journal, April 27, 2015
To the extent the states’ actions can be explained by a common denominator, it is expediency. The actual “earnest desire” at work is not a more humane manner of death, but a different goal: to carry out executions without disruption. States design their execution procedures based on which drugs are available, not serious medical or scientific inquiry.
Megan McCracken quoted in The New York Times, April 26, 2015
“This is an opportunity for the court to prevent other states from adopting a drug that has been so problematic,” Ms. McCracken said.
Barry Krisberg quoted in Los Angeles Times, April 25, 2015
Barry Krisberg … said the alternative justice lobby is unlikely to affect lawmakers’ votes on criminal penalties. “The politicians are still pretty frightened about crossing the law enforcement unions.”
Franklin Zimring and Barry Krisberg cited in UT San Diego, April 24, 2015
Zimring: Because of prison realignment (to county jails) and other policies in response to federal prison overcrowding orders, California has undertaken “a pretty substantial experiment in decarceration,” he added, and yet crime just keeps falling.
Krisberg says many Republicans—typically leaders of the law-and-order coalition—now often back changes that help reduce costs and incarceration rates, even as some Democrats oppose them because of their closeness to the prison guards and police unions.
Steven Davidoff Solomon writes for The New York Times, April 24, 2015
Teva’s unsolicited $40 billion bid for the drug maker Mylan and Mylan’s own unsolicited offer for the rival Perrigo are sweet revenge for the United States taxpayer. The reason is their flight from the United States in tax inversions has made both more exposed to hostile takeovers.
Steven Davidoff Solomon writes for The New York Times, April 21, 2015
The shifting landscape of shareholder activism perhaps signals a transition. With more players and money pursuing it, companies seem to be adopting a more nuanced strategy that takes into account the fact that not all activists are alike.
Steven Wiessman quoted on SNL.com, April 20, 2015
“The commission interface is with the company itself and not with individuals,” Weissman, who previously served as a CPUC administrative law judge, said in an April 16 interview, noting that utilities have relative freedom in how they spend the money the commission awards in rates — including with respect to executive compensation.
Stephen Sugarman quoted in San Jose Mercury News, April 18, 2015
“We interfere with people’s liberty in the name of public health in many ways,” said Sugarman. … He pointed out that individuals with tuberculosis can be quarantined, while chemicals are added into the public water supply to fight tooth decay. He said if objecting parents “lose this battle in Sacramento, I don’t think that the courts are the right place to provide them with relief in this instance.”
David Gamage quoted in KQED News, April 15, 2015
David Gamage … says the 1099-K could be a part of a business strategy…. “It’s entirely possible that a primary reason for their adopting these structures is to want to distance themselves from the actions of their drivers.”